Search results
Results from the WOW.Com Content Network
In its treatment guidelines, the American College of Gastroenterology has suggested peppermint oil for relief of IBS symptoms such as abdominal pain. The group based its verdict on a number...
Recent studies have shown that peppermint oil can help relieve common IBS symptoms like pain and bloating. WebMD shows you how it works, how much to take, and if it’s safe for you.
PRISMA flowchart illustrating the process for the selection of the included articles for the systematic review and for the data synthesis of the randomized controlled clinical trials of enteric-coated peppermint oil versus placebo in patients with irritable bowel syndrome (IBS).
Peppermint oil has been shown to be effective in relieving symptoms of irritable bowel syndrome (IBS) in some people, particularly in reducing abdominal pain, bloating, and discomfort. Peppermint ...
An exception: There is some evidence that peppermint may reduce symptoms of irritable bowel syndrome (IBS). This article discusses the health benefits of peppermint and the possible side effects. It also covers appropriate dosages and what to look for when buying it.
Peppermint oil, which is extracted from the stem, leaves, and flowers of the plant, has become popular as a treatment for a variety of conditions, including irritable bowel syndrome (IBS ...
We read the randomized controlled trial (RCT) by Weerts et al1 of peppermint oil versus placebo, in irritable bowel syndrome (IBS), with interest.
Patients who received PO had a significant improvement in their reported IBS score compared to placebo, with a pooled RR of 1.83 [95% CI: 1.25-2.67, I 2 = 49%, P=0.002]. The pooled risk ratio was 2.12 [95% CI: 1.28-3.52, I 2 = 59%] for improvement in intensity of IBS symptoms, favoring PO (P=0.004).
Nine randomized placebo-controlled studies have found peppermint oil to be a safe and effective treatment for irritable bowel syndrome.
These ACG guidelines do recommend peppermint oil for overall symptom improvement in patients with IBS, although the recommendation and quality of evidence is considered weak and low, respectively.